Insufficient scRNA-seq data for expression of PLSCR3 at single-cell level.
Insufficient scRNA-seq data for expression of PLSCR3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2683.84 | 1445 / 1445 | 1% | 0.01 | 1 / 183 |
ovary | 100% | 2590.75 | 180 / 180 | 0% | 0.01 | 2 / 430 |
intestine | 100% | 2059.99 | 965 / 966 | 0% | 0.00 | 1 / 527 |
adipose | 100% | 3313.69 | 1204 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 100% | 1904.95 | 258 / 258 | 0% | 0 | 0 / 230 |
bladder | 100% | 3049.62 | 21 / 21 | 0% | 0 | 0 / 504 |
breast | 100% | 3151.46 | 459 / 459 | 0% | 0 | 0 / 1118 |
kidney | 100% | 1908.24 | 89 / 89 | 0% | 0 | 0 / 901 |
prostate | 100% | 2377.73 | 245 / 245 | 0% | 0 | 0 / 502 |
skin | 100% | 3421.68 | 1809 / 1809 | 0% | 0 | 0 / 472 |
spleen | 100% | 3813.23 | 241 / 241 | 0% | 0 | 0 / 0 |
stomach | 100% | 1592.58 | 359 / 359 | 0% | 0 | 0 / 286 |
thymus | 100% | 2255.55 | 653 / 653 | 0% | 0 | 0 / 605 |
uterus | 100% | 3693.03 | 170 / 170 | 0% | 0 | 0 / 459 |
blood vessel | 100% | 3183.94 | 1334 / 1335 | 0% | 0 | 0 / 0 |
lung | 100% | 3027.27 | 577 / 578 | 0% | 0.00 | 1 / 1155 |
heart | 100% | 1696.25 | 859 / 861 | 0% | 0 | 0 / 0 |
muscle | 99% | 1129.51 | 793 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 2046.79 | 913 / 929 | 0% | 0 | 0 / 0 |
liver | 95% | 749.68 | 215 / 226 | 0% | 0 | 0 / 406 |
brain | 95% | 835.84 | 2498 / 2642 | 0% | 0 | 0 / 705 |
pancreas | 93% | 845.30 | 306 / 328 | 0% | 0 | 0 / 178 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0090199 | Biological process | regulation of release of cytochrome c from mitochondria |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0032049 | Biological process | cardiolipin biosynthetic process |
GO_0006915 | Biological process | apoptotic process |
GO_0017121 | Biological process | plasma membrane phospholipid scrambling |
GO_0042593 | Biological process | glucose homeostasis |
GO_0042632 | Biological process | cholesterol homeostasis |
GO_0005886 | Cellular component | plasma membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0045340 | Molecular function | mercury ion binding |
GO_0017128 | Molecular function | phospholipid scramblase activity |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0048306 | Molecular function | calcium-dependent protein binding |
GO_0032791 | Molecular function | lead ion binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0017124 | Molecular function | SH3 domain binding |
Gene name | PLSCR3 |
Protein name | Phospholipid scramblase Phospholipid scramblase 3 Phospholipid scramblase 3 (PL scramblase 3) (Ca(2+)-dependent phospholipid scramblase 3) |
Synonyms | |
Description | FUNCTION: Catalyzes calcium-induced ATP-independent rapid bidirectional and non-specific movement of the phospholipids (lipid scrambling or lipid flip-flop) between the inner and outer membrane of the mitochondria . Plays an important role in mitochondrial respiratory function, morphology, and apoptotic response . Mediates the translocation of cardiolipin from the mitochondrial inner membrane to outer membrane enhancing t-Bid induced cytochrome c release and apoptosis . Enhances TNFSF10-induced apoptosis by regulating the distribution of cardiolipin in the mitochondrial membrane resulting in increased release of apoptogenic factors and consequent amplification of the activity of caspases . Regulates cardiolipin de novo biosynthesis and its resynthesis . . FUNCTION: May mediate accelerated ATP-independent bidirectional transbilayer migration of phospholipids upon binding calcium ions that results in a loss of phospholipid asymmetry in the plasma membrane. . FUNCTION: May mediate accelerated ATP-independent bidirectional transbilayer migration of phospholipids upon binding calcium ions that results in a loss of phospholipid asymmetry in the plasma membrane. . FUNCTION: May mediate accelerated ATP-independent bidirectional transbilayer migration of phospholipids upon binding calcium ions that results in a loss of phospholipid asymmetry in the plasma membrane. . FUNCTION: May mediate accelerated ATP-independent bidirectional transbilayer migration of phospholipids upon binding calcium ions that results in a loss of phospholipid asymmetry in the plasma membrane. . |
Accessions | ENST00000576201.5 ENST00000576362.5 Q9NRY6 ENST00000571078.5 I3L1V1 ENST00000571802.1 I3L1P6 I3L161 ENST00000619711.5 ENST00000640375.1 ENST00000639780.1 I3L4F5 I3NI29 I3L3X5 ENST00000573070.5 ENST00000574401.5 ENST00000324822.15 ENST00000573213.1 ENST00000575434.4 ENST00000640053.1 ENST00000639874.2 |